Nipro Medical Corporation
Explore this company’s associated devices, FDA decisions and regulatory history.

Nipro Medical Corporation
- Regulatory records
- 3
- Linked recall entries
- 1
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 3 FDA records to the applicant name Nipro Medical Corporation. The collection includes 3 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 19, 2026 to Jul 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FMI appears in 1 of the 3 linked filings. The collection spans 3 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 3150 NW 107th Ave., Miami, FL, 33172, US. Recorded on K261399, decision dated Jul 28, 2026.
Device categories in this collection
Hemodialyzer With Expanded Solute Removal Profile; Needle, Hypodermic, Single Lumen; Dialyzer, High Permeability With Or Without Sealed Dialysate System.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Nipro Medical Corporation | Class II | Dec 17, 2025 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ELISIO-HXK261399 | Nipro Medical Corporation | 510(k) clearance | Jul 28, 2026 | FDA |
PRESSONEK253047 | Nipro Medical Corporation | 510(k) clearance | Mar 24, 2026 | FDA |
ELISIO-HK260533 | Nipro Medical Corporation | 510(k) clearance | Mar 19, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.



